Stocklytics Platform
Asset logo for symbol ATNM
Actinium Pharmaceuticals
ATNM46
$1.81arrow_drop_up1.68%$0.03
Penny Stock
Asset logo for symbol ATNM
ATNM46

$1.81

arrow_drop_up1.68%
query_stats

ATNM is not a dividend stock

Therefore Dividends subscore should not be taken into consideration

For certain stocks classified as non-dividend stocks, dividend-related data may not be available or applicable. Non-dividend stocks are those where the company does not regularly distribute dividends to its shareholders.

Why No Data?

Non-dividend stocks typically do not offer regular dividend payments. As a result, there might be no dividend-related information or history for such stocks within our database.

Understanding Non-Dividend Stocks

Non-dividend stocks are characterized by companies that reinvest their profits back into the business for expansion, research, development, or other strategic purposes rather than distributing dividends to shareholders.

What This Means for Investors

Investors in non-dividend stocks often focus on capital appreciation, anticipating the value of their shares to increase over time without relying on dividend income.

Stay Updated

While dividend information may not be available for these stocks, other critical financial metrics and analyses are accessible on Stocklytics to aid in informed investment decisions.

Stock Split History (ATNM)

DateSplitMultipleCumulative
Multiple
Aug 11, 20201:30x0x0
Dec 19, 20071:2x0.5x0.5

Actinium Pharmaceuticals (ATNM) Dividends & Splits

Actinium Pharmaceuticals Inc (ATNM) does not currently offer dividends to its shareholders. The company is primarily focused on the development and commercialization of innovative targeted therapies for patients with cancer. As a biopharmaceutical company, Actinium Pharmaceuticals is more interested in investing its resources in research and development to advance its pipeline of potential cancer treatments. Therefore, shareholders should not expect to receive any dividend payments from the company at the moment.
Similarly, Actinium Pharmaceuticals Inc (ATNM) has not undergone any recent stock splits. A stock split occurs when a company divides its existing shares into multiple shares, thereby increasing the number of shares outstanding. This is typically done to make the stock more affordable and accessible to a broader range of investors. However, Actinium Pharmaceuticals has not announced any stock splits in its history. As a result, the company's stock price is not expected to be affected by any split-related adjustments. Investors should be mindful of this if they plan to invest in Actinium Pharmaceuticals Inc (ATNM).
add Actinium Pharmaceuticals  to watchlist

Keep an eye on Actinium Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

Does Actinium Pharmaceuticals (ATNM) stock pay dividends?

No, Actinium Pharmaceuticals (ATNM) does not pay dividends. This could indicate that the company is currently focusing on reinvesting its earnings into growth opportunities rather than distributing them as dividends.
help

When was the last Actinium Pharmaceuticals (ATNM) stock split?

Actinium Pharmaceuticals (ATNM) has undergone 2 total stock splits. The most recent split was a 1:30 split on 2020 Aug 11, leaving the company with 31.15M shares outstanding. Since the company's inception, the cumulative multiple from splits is 0, indicating the overall effect of all splits on the original share count.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media